171 related articles for article (PubMed ID: 10482909)
1. Differentiated effects on splanchnic homeostasis by selective and non-selective endothelin receptor antagonism in porcine endotoxaemia.
Oldner A; Wanecek M; Weitzberg E; Sundin P; Sollevi A; Rubio C; Hellström PM; Alving K; Rudehill A
Br J Pharmacol; 1999 Aug; 127(8):1793-804. PubMed ID: 10482909
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor antagonism increases gut oxygen delivery but fails to improve intestinal mucosal acidosis in porcine endotoxin shock.
Oldner A; Wanecek M; Weitzberg E; Rundgren M; Alving K; Ullman J; Rudehill A
Shock; 1999 Feb; 11(2):127-35. PubMed ID: 10030800
[TBL] [Abstract][Full Text] [Related]
3. The endothelin receptor antagonist bosentan restores gut oxygen delivery and reverses intestinal mucosal acidosis in porcine endotoxin shock.
Oldner A; Wanecek M; Goiny M; Weitzberg E; Rudehill A; Alving K; Sollevi A
Gut; 1998 May; 42(5):696-702. PubMed ID: 9659167
[TBL] [Abstract][Full Text] [Related]
4. Endothelin-mediated gut microcirculatory dysfunction during porcine endotoxaemia.
Andersson A; Fenhammar J; Weitzberg E; Sollevi A; Hjelmqvist H; Frithiof R
Br J Anaesth; 2010 Nov; 105(5):640-7. PubMed ID: 20710019
[TBL] [Abstract][Full Text] [Related]
5. Effects on haemodynamics by selective endothelin ET(B) receptor and combined endothelin ET(A)/ET(B) receptor antagonism during endotoxin shock.
Wanecek M; Oldner A; Sundin P; Alving K; Weitzberg E; Rudehill A
Eur J Pharmacol; 1999 Dec; 386(2-3):235-45. PubMed ID: 10618475
[TBL] [Abstract][Full Text] [Related]
6. Mixed endothelin receptor antagonism with tezosentan improves intestinal microcirculation in endotoxemic shock.
Andersson A; Fenhammar J; Frithiof R; Weitzberg E; Sollevi A; Hjelmqvist H
J Surg Res; 2008 Sep; 149(1):138-47. PubMed ID: 18639249
[TBL] [Abstract][Full Text] [Related]
7. Synthetic atrial natriuretic peptide improves systemic and splanchnic circulation and has a lung-protective effect during endotoxemia in pigs.
Sekino M; Makita T; Ureshino H; Sungsam C; Sumikawa K
Anesth Analg; 2010 Jan; 110(1):141-7. PubMed ID: 19933537
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological properties of J-104132 (L-753,037), a potent, orally active, mixed ETA/ETB endothelin receptor antagonist.
Nishikibe M; Ohta H; Okada M; Ishikawa K; Hayama T; Fukuroda T; Noguchi K; Saito M; Kanoh T; Ozaki S; Kamei T; Hara K; William D; Kivlighn S; Krause S; Gabel R; Zingaro G; Nolan N; O'Brien J; Clayton F; Lynch J; Pettibone D; Siegl P
J Pharmacol Exp Ther; 1999 Jun; 289(3):1262-70. PubMed ID: 10336515
[TBL] [Abstract][Full Text] [Related]
9. Nonselective ETA/ETB-receptor blockade increases systemic blood pressure of Bio 14.6 cardiomyopathic hamsters.
Honoré JC; Carrier E; Fecteau MH; Tirapelli CR; Bkaily G; D'Orleans-Juste P
Can J Physiol Pharmacol; 2008 Jun; 86(6):394-401. PubMed ID: 18516103
[TBL] [Abstract][Full Text] [Related]
10. Activation of either the ETA or the ETB receptors is involved in the development of electrographic seizures following intrahippocampal infusion of the endothelin-1 in immature rats.
Tsenov G; Vondrakova K; Otahal J; Burchfiel J; Kubova H
Exp Neurol; 2015 Mar; 265():40-7. PubMed ID: 25542981
[TBL] [Abstract][Full Text] [Related]
11. Functional and binding characterization of endothelin receptors in human bronchus: evidence for a novel endothelin B receptor subtype?
Hay DW; Luttmann MA; Pullen MA; Nambi P
J Pharmacol Exp Ther; 1998 Feb; 284(2):669-77. PubMed ID: 9454813
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory responses after endothelin B (ETB) receptor activation in human monocytes: new evidence for beneficial anti-inflammatory potency of ETB-receptor antagonism.
Juergens UR; Racké K; Uen S; Haag S; Lamyel F; Stöber M; Gillissen A; Novak N; Vetter H
Pulm Pharmacol Ther; 2008; 21(3):533-9. PubMed ID: 18295521
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of two novel mixed ETA/ETB receptor antagonists, BQ-928 and 238, in the carotid and pulmonary arteries and the perfused kidney of the rabbit.
Maurice MC; Gratton JP; D'Orléans-Juste P
Br J Pharmacol; 1997 Jan; 120(2):319-25. PubMed ID: 9117126
[TBL] [Abstract][Full Text] [Related]
14. Circulatory responses to endothelin-1 and nitric oxide with special reference to endotoxin shock and nitric oxide inhalation.
Weitzberg E
Acta Physiol Scand Suppl; 1993; 611():1-72. PubMed ID: 8379340
[TBL] [Abstract][Full Text] [Related]
15. Receptor-mediated effects of endothelin on the L-type Ca++ current in ventricular cardiomyocytes.
Kelso EJ; Spiers JP; McDermott BJ; Scholfield CN; Silke B
J Pharmacol Exp Ther; 1998 Aug; 286(2):662-9. PubMed ID: 9694918
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of inducible nitric oxide synthase (iNOS) inhibition-related improvement of gut mucosal acidosis during hyperdynamic porcine endotoxemia.
Pittner A; Nalos M; Asfar P; Yang Y; Ince C; Georgieff M; Brückner UB; Radermacher P; Fröba G
Intensive Care Med; 2003 Feb; 29(2):312-6. PubMed ID: 12594592
[TBL] [Abstract][Full Text] [Related]
17. Systemic and hepatosplanchnic hemodynamic and metabolic effects of the PARP inhibitor PJ34 during hyperdynamic porcine endotoxemia.
Iványi Z; Hauser B; Pittner A; Asfar P; Vassilev D; Nalos M; Altherr J; Brückner UB; Szabó C; Radermacher P; Fröba G
Shock; 2003 May; 19(5):415-21. PubMed ID: 12744483
[TBL] [Abstract][Full Text] [Related]
18. Effects of levosimendan in normodynamic endotoxaemia: a controlled experimental study.
Dubin A; Maskin B; Murias G; Pozo MO; Sottile JP; Barán M; Edul VS; Canales HS; Estenssoro E
Resuscitation; 2006 May; 69(2):277-86. PubMed ID: 16458408
[TBL] [Abstract][Full Text] [Related]
19. Haemodynamic influence and endothelin-1 plasma concentrations by selective or non-selective endothelin receptor antagonists in the pig in vivo.
Holm P; Franco-Cereceda A
Acta Physiol Scand; 1999 Feb; 165(2):163-8. PubMed ID: 10090327
[TBL] [Abstract][Full Text] [Related]
20. Role of the endothelin system in secondary pulmonary hypertension related to air embolism: lessons learned from testing four classes of endothelin blockers in a rat model.
Battistini B; Verreault M; Ayach B; Blouin A; Cernacek P; Jeng AY; Wessale J; Opgenorth T; Tsang J
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S386-9. PubMed ID: 15838327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
